20th Jan 2021 08:19
Ap19
FORM 8.3 - Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 15 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,583,529 | 2.00% | 601,023 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
372,523 | 0.29% | 445,393 | 0.35% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,962,052 | 2.30% | 1,052,416 | 0.82% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 204.5300 USD |
Purchase | 1 | 207.0200 USD |
Purchase | 76 | 204.1300 USD |
Purchase | 100 | 206.8500 USD |
Purchase | 106 | 206.1800 USD |
Purchase | 300 | 205.3917 USD |
Purchase | 300 | 206.8466 USD |
Purchase | 300 | 206.5066 USD |
Purchase | 441 | 206.0897 USD |
Purchase | 500 | 206.5190 USD |
Purchase | 500 | 206.6610 USD |
Purchase | 583 | 206.7342 USD |
Purchase | 659 | 206.5700 USD |
Purchase | 736 | 204.8377 USD |
Purchase | 800 | 206.0807 USD |
Purchase | 800 | 206.4025 USD |
Purchase | 876 | 206.7573 USD |
Purchase | 900 | 206.3983 USD |
Purchase | 1,000 | 206.5215 USD |
Purchase | 1,400 | 205.6023 USD |
Purchase | 1,620 | 206.6338 USD |
Purchase | 4,166 | 205.8461 USD |
Purchase | 4,294 | 205.6958 USD |
Purchase | 4,682 | 206.4017 USD |
Purchase | 5,286 | 206.6199 USD |
Purchase | 5,384 | 206.4057 USD |
Purchase | 15,989 | 206.6500 USD |
Purchase | 17,904 | 206.4440 USD |
Purchase | 30,284 | 206.3113 USD |
Sale | 3 | 206.9200 USD |
Sale | 62 | 206.8400 USD |
Sale | 71 | 206.9657 USD |
Sale | 80 | 205.0000 USD |
Sale | 92 | 206.6126 USD |
Sale | 100 | 205.2300 USD |
Sale | 100 | 206.8450 USD |
Sale | 100 | 204.2200 USD |
Sale | 100 | 206.8500 USD |
Sale | 100 | 206.6800 USD |
Sale | 100 | 206.3950 USD |
Sale | 118 | 206.5568 USD |
Sale | 143 | 205.3300 USD |
Sale | 179 | 206.3889 USD |
Sale | 200 | 206.0618 USD |
Sale | 203 | 204.6697 USD |
Sale | 220 | 206.5122 USD |
Sale | 400 | 205.2400 USD |
Sale | 400 | 205.2200 USD |
Sale | 436 | 205.0700 USD |
Sale | 500 | 206.0030 USD |
Sale | 778 | 206.4569 USD |
Sale | 1,241 | 206.2426 USD |
Sale | 1,552 | 206.4974 USD |
Sale | 1,747 | 206.4860 USD |
Sale | 2,236 | 206.3409 USD |
Sale | 2,932 | 205.6785 USD |
Sale | 3,389 | 206.4260 USD |
Sale | 4,295 | 205.6961 USD |
Sale | 4,727 | 206.6164 USD |
Sale | 5,400 | 206.4578 USD |
Sale | 7,043 | 206.4655 USD |
Sale | 15,065 | 206.6500 USD |
Sale | 19,243 | 206.2094 USD |
Sale | 25,241 | 206.4713 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product Name | Writing, | Number | Exercise | Type | Expiry | Option |
| purchasing, | of | price | date | money | ||
| selling, | securities | paid/ | ||||
| varying etc | to which | received | ||||
| option | ||||||
| relates | ||||||
Call Option | Purchasing | 6,000 | 220 USD | American | 16 Jul 2021 | 9.3170 USD |
Put Option | Purchasing | 6,000 | 200 USD | American | 16 Jul 2021 | 13.6830 USD |
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 20 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210120005222/en/
Copyright Business Wire 2021
Related Shares:
Barclays